Your browser doesn't support javascript.
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower.
Nowell, W Benjamin; Gavigan, Kelly; Kannowski, Carol L; Cai, Zhihong; Hunter, Theresa; Venkatachalam, Shilpa; Birt, Julie; Workman, Jennifer; Curtis, Jeffrey R.
  • Nowell WB; Global Healthy Living Foundation, Upper Nyack, NY, USA. bnowell@ghlf.org.
  • Gavigan K; Global Healthy Living Foundation, Upper Nyack, NY, USA.
  • Kannowski CL; Eli Lilly and Company, Indianapolis, IN, USA.
  • Cai Z; Eli Lilly Japan, Kobe, Japan.
  • Hunter T; Eli Lilly and Company, Indianapolis, IN, USA.
  • Venkatachalam S; Global Healthy Living Foundation, Upper Nyack, NY, USA.
  • Birt J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Workman J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Curtis JR; University of Alabama at Birmingham, Birmingham, AL, USA.
Arthritis Res Ther ; 23(1): 53, 2021 02 10.
Article in English | MEDLINE | ID: covidwho-1090623
ABSTRACT

BACKGROUND:

Patient-reported outcomes (PROs) are increasingly used to track symptoms and to assess disease activity, quality of life, and treatment effectiveness. It is therefore important to understand which PROs patients with rheumatic and musculoskeletal disease consider most important to track for disease management.

METHODS:

Adult US patients within the ArthritisPower registry with ankylosing spondylitis, fibromyalgia syndrome, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, and systemic lupus erythematosus were invited to select between 3 and 10 PRO symptom measures they felt were important to digitally track for their condition via the ArthritisPower app. Over the next 3 months, participants (pts) were given the option to continue tracking their previously selected measures or to remove/add measures at 3 subsequent monthly time points (month [m] 1, m2, m3). At m3, pts prioritized up to 5 measures. Measures were rank-ordered, summed, and weighted based on pts rating to produce a summary score for each PRO measure.

RESULTS:

Among pts who completed initial selection of PRO assessments at baseline (N = 253), 140 pts confirmed or changed PRO selections across m1-3 within the specified monthly time window (28 days ± 7). PROs ranked as most important for tracking were PROMIS Fatigue, Physical Function, Pain Intensity, Pain Interference, Duration of Morning Joint Stiffness, and Sleep Disturbance. Patient's preferences regarding the importance of these PROs were stable over time.

CONCLUSION:

The symptoms that rheumatology patients prioritized for longitudinal tracking using a smartphone app were fatigue, physical function, pain, and morning joint stiffness.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Humans Language: English Journal: Arthritis Res Ther Journal subject: Rheumatology Year: 2021 Document Type: Article Affiliation country: S13075-021-02430-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Humans Language: English Journal: Arthritis Res Ther Journal subject: Rheumatology Year: 2021 Document Type: Article Affiliation country: S13075-021-02430-0